← Open Payments lookup

DUSAN PEKOVIC: Open Payments

NPI 1568532687 · NEW YORK CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,962 in 89 payments from 13 companies in 2025. Trend: 2023 $5,910 · 2024 $3,982 · 2025 $2,962

Food & beverage: $2,962
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.14$428
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$423
E.R. Squibb & Sons, L.L.C.7$376
ABBVIE INC.15$357
Lundbeck LLC12$319
Otsuka America Pharmaceutical, Inc.10$258
Alkermes, Inc.8$256
Axsome Therapeutics, Inc.3$172
Takeda Pharmaceuticals U.S.A., Inc.7$172
Janssen Pharmaceuticals, Inc3$92

Products named: FANAPT, CAPLYTA, COBENFY, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, LYBALVI, Auvelity.

Industry payments across NY — which companies pay providers there.